October Brings More Progress For Pot Stocks 

October Brings More Progress For Pot Stocks 



October Brings More Progress For Pot Stocks  – Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™





































Published at Wed, 16 Oct 2019 19:09:05 +0000

Nextleaf Solutions Enters into Agreement to Consolidate Nextleaf Labs

Nextleaf Solutions Enters into Agreement to Consolidate Nextleaf Labs

Nextleaf Solutions Ltd. (“Nextleaf“, “OILS“, or the “Company“) (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) a Vancouver-based extraction technology company that owns a portfolio of eight (8) issued and over 35 pending patents pertaining to industrial-scale extraction, purification and formulation of cannabinoids, announced today that it has entered into an agreement with its commercialization partner, Nextleaf Labs Ltd. (“Labs“), a Standard Processor licensed under the Cannabis Regulations.

Through Nextleaf’s existing intellectual property (IP) and infrastructure, OILS will be able to extract, refine, purify, and formulate cannabinoids such as THC and CBD, the precursor ingredients for a variety of infused cannabis products becoming legal in Canada later this week.

“With this consolidation, we will expand on our foundation from developing intellectual property, into the delivery of toll processing and white labeling services to leverage OILS’ IP through Labs’ Standard Processing Licence,” said Paul Pedersen, co-founder and CEO of OILS.

The 6,540 sq. ft. facility, located in the Greater Vancouver Area, was granted a Standard Processor licence on September 6, 2019. The licensing process was led by Tom Ulanowski, President of Nextleaf Labs Ltd. “Nextleaf has developed efficient, scalable technology for the cannabis and hemp extraction industry, and has protected their IP in a number of jurisdictions where cannabis is – or will likely be – legal,” said Mr. Ulanowski. “At this time, our focus is on commissioning the phase one custom extraction and purification system and finalizing commercial contracts, in time for the next wave of legal cannabis products.”

In his previous role as Quality Assurance Person (QAP) and Qualified Person in Charge (QPIC) at British Columbia’s first Licensed Producer, Mr. Ulanowski quality-assured hundreds of batches of cannabis, while helping to obtain multiple production and sales licences, win national industry awards, and increase output ten-fold via facility expansions, improvements to current practices, and the development of new processes and products. In 2018, Mr. Ulanowski led the effort to manufacture and bring to market the first legal concentrated cannabis product to be sold in Canada.

Mr. Ulanowski has also been integral in developing Kwantlen Polytechnic University’s (KPU’s) Cannabis Professional Series courses, and has taught hundreds of students around the world about cannabis production and the interpretation of national and international cannabis laws and regulations.

Under the share purchase agreement for the acquisition of Labs by Nextleaf, the Company will issue 1,000,000 common shares (the “Shares“) to Mr. Ulanowski at a deemed price of $0.385 per Share for aggregate consideration of $385,000. The Shares issued under the agreement will be subject to a pooling arrangement which restricts the ability of the holder to transfer or trade the Shares. The Shares will be released from the pooling arrangement over a period of 18 months, with 25% of the Shares released immediately upon completion of the acquisition and the balance released in three equal tranches every six months thereafter.

Options Grant

The Company has awarded key management of the Company 300,000 options, pursuant to the Company’s Stock Option Plan, exercisable at a price of $0.50 per common share, vesting in December 2020.

About Nextleaf Solutions

Nextleaf Solutions Ltd. (“OILS”) is developing disruptive intellectual property for industrial-scale extraction, purification and formulation of cannabinoids. OILS owns a portfolio of eight (8) issued and over 35 pending patents pertaining to the production of high-purity, cannabinoid rich distillate, the key ingredient used in the manufacturing of standardized THC and CBD infused products. Once cannabis concentrates and edibles become legal across Canada, OILS plans to commercialize its intellectual property portfolio through IP licensing, B2B processing services, and the supply of THC and CBD oils and concentrates to qualified Canadian and international partners.

Share

Share - Facebook


Share - Twitter

Authored By

Anthony Varrell

Anthony Varrell is Managing Director of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Published at Tue, 15 Oct 2019 12:25:14 +0000

1933 Industries Provides a Corporate Update

1933 Industries Provides a Corporate Update

1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, is pleased to provide an update regarding its operations.

CSE:TGIF, OTCQX: TGIFF (CNW Group/1933 Industries Inc.)

Highlights:

  • 1933 Industries continues to focus its operations in the licensed US cannabis industry as a multi-state operator in Nevada, Colorado and California.
  • 1933 Industries is a two-year old company built with sustainability and profitability as its primary goals and continues to execute on its growth plan.
  • The Company has instituted capital efficient practices to operate a lean and sustainable business with scalable profitability as its main objective.
  • The Company maintains a strong balance sheet with cash on hand to fund capital projects, the ability to service its debenture payments and currently holds no other debt.
  • Experienced in the cannabis industry, the operationally focused management team raised approximately $36M over the last two years and has added $60M in assets to the Company.
  • Three major capital projects were undertaken by management in order to build expanded infrastructure capacity for cannabis flower cultivation, production of concentrates, and hemp-derived CBD extraction in Nevada.
  • Cultivation facility in Las Vegas was completed and the first harvest is now expected in December, bringing a 5-fold increase in flower production and raw materials for cannabis concentrates.
  • New manufacturing facility in California is coming online in November as well as expanded cultivation capacity for the Company’s AMA premium flower brand.
  • The Company’s proprietary Canna Hemp™ wellness line continues to establish itself as a premier CBD brand across the US and is now available in over 800 retail outlets.
  • World-renowned brands such as OG DNA Genetics, and The Original Jack Herer® selected the Company’s subsidiary, Alternative Medicine Association, as their exclusive partner in Nevada, as well as luxury brand Blonde™ Cannabis, leading concentrate producer Denver Dab Co., premium cannabis brand Gotti’s Gold and custom hardware manufacturer PLUGplay.
  • Leading specialty retailer Zumiez is now carrying the Company’s CBD Canna Hemp X™ sports cream, which was launched in collaboration with top skateboarding company Grizzly Griptape.
  • The exclusive Birdhouse Skateboards™/Canna Hemp X™ co-branded sports cream is set to launch in November and will be available at US Zumiez stores.

Fiscal Responsibility, Strong Balance Sheet and Cash Position
The Company recently provided guidance on its Q4 financial results (see news release dated September 12, 2019) and will be announcing its Annual Financial Report by the regulatory deadline of November 30th.

1933 Industries is a two-year old company built with sustainability and profitability as its primary goals and continues to execute on its growth plan. The Company sold its purpose-built cultivation facility and negotiated a 10-year lease-back agreement to operate one of Nevada’s largest indoor cultivation facilities for premium craft cannabis (see news release dated May 15, 2019). Gross proceeds of $10.45M are being utilized to fund infrastructure projects in Nevada and California, to open new markets in Arizona and Colorado, and to continue the expansion of its Canna Hemp™ consumer branded goods across the US. Management has built significant sequential growth, quarter after quarter, year over year, building a continued path towards profitability once all projects become fully operational. Additionally, the Company has streamlined its business units to significantly improve operational efficiencies across and reduce corporate overhead.

Expanding Cultivation Capacity in Nevada and California
The Company recently reported that it expects the first harvest of high premium flower from its new cultivation facility in Las Vegas in December, with subsequent harvests every two-weeks thereafter (news release dated September 30, 2019). The completion of the 67,750 sq. ft. purpose-built, indoor facility was a major milestone for the Company as it positions itself as the largest wholesale supplier of premium craft flower to licensed dispensaries and ensures the consistent supply of raw materials for the Company’s AMA product line and licensing partners. The expected output of 700 lbs. of cannabis flower is a 5-fold increase in production and the Company expects that all flower rooms will be filled and harvesting on a continuing basis by January, 2020.

The cultivation and manufacturing buildout in California is on schedule to be completed by the end of October and will be in production by November. The California operation is managed by the Company, but owned by a third party (news release dated August 15, 2019). Both the Nevada and California facilities bring almost 80,000 sq. ft. of total cultivation space to the Company while positioning the Company to maximize cultivation and extraction capabilities in both states.

New Extraction Facilities in Progress
The Company reports that the renovation to increase the footprint of its current extraction facility is on track to receive construction permits from Clark County this week. The construction will take three months to complete, which will double the Company’s extraction and production capabilities (news release dated July 12, 2019).

The Company’s hemp-derived cannabidiol (CBD) extraction facility (Hemp Lab) under development is being designed with the capacity to isolate cannabinoids such as CBD, CBN and CBG, at commercial scale volumes in order to utilize all isolates in the manufacturing of the Company’s own proprietary branded products, with the aim of increasing product margins and bringing online a new, recurring revenue stream. The Company will be providing a full update on its Hemp Lab once it finalizes the timing of equipment delivery, county approvals and engineering plans.

Positioning Canna Hemp as the Premier CBD product line in the US
As a brand-focused company, building a strong portfolio of high margin, industry-leading brands that have wide appeal to consumers is a key priority for the Company. With wholesale partnerships, nationwide reach of its products, and a new partnership with Zumiez retailer in the US, the Company has added an e-Commerce channel with a revamped website portal and upcoming marketing campaigns targeting mainstream media.

The Company’s sports cream, Canna Hemp X™, a collaboration with Grizzly Griptape, targets a growing consumer following from the skateboarding, BMX, snowboarding, motocross and MMA fields of sport. Working through brand ambassadors in all the above sports, the Company is building a brand that resonates with athletes of all levels. The Company has executed licensing agreements with best of breed names including Grizzly Griptape and Birdhouse Skateboards™, with the latter soon to launch a co-branded Birdhouse/Canna Hemp X™ CBD Balm in November. Marketing campaigns will include skateboarding legend Mr. Tony Hawk, Mr. Clive Dixon, Mr. David Loy as well as other Birdhouse team riders to promote the collaboration. The Company continues to build on its ambassador and influencer programs, with the aim to build teams across the main focus sports noted above.

Management Commentary
Mr. Chris Rebentisch, CEO of the Company remarked, “We are pleased to report that we have never been in a stronger position as a company. We are fully capitalized to execute on our strategy, without having to raise capital and with no debt in our books. With multiple projects coming online over the next months that will increase revenues, we will continue to build our strongest brand portfolio to date while we work towards profitability. We confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. The current share price is not representative of the performance of our operations.”

Mr. Brayden Sutton, Chairman of the Board added, “We have a solid balance sheet that demonstrates the strength of the management team and its expertise as operators in the cannabis space with a long history of execution in the consumer packaged goods sector. We continue to build one of the most impressive ‘House of Brands’ in the market with increasing revenues and distribution. We are in the enviable position to weather market pressures until the sector recovers, and we believe that in the changing landscape of the cannabis industry, companies such as ours with strong fundamentals will become the next phase of the cannabis industry, one that will be distinguished by quality products, safety of ingredients and brand affinity.”

About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets.

Our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Birdhouse Skateboards™, Blonde™ Cannabis, Denver Dab Co., Gotti’s Gold, Grizzly Griptape, OG DNA Genetics, PLUGplay, and The Original Jack Herer®.

The Company owns 91% of Alternative Medicine Association, LLC (AMA), and 100% of Infused MFG LLC.

About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
http://www.cannahemp.com
https://www.leafly.com/news/strains-products/best-in-state-2018-nevada-cannabis

About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
http://www.cannahempx.com
https://herb.co/learn/best-cannabis-products/

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/1933-industries-provides-a-corporate-update-300938493.html

SOURCE 1933 Industries Inc.

Published at Tue, 15 Oct 2019 12:32:10 +0000

MedMen-PharmaCann Acquisition Falls Apart, New Report Says Vaping-Related Illnesses Similar to Chemical Burns: Week in Review

MedMen-PharmaCann Acquisition Falls Apart, New Report Says Vaping-Related Illnesses Similar to Chemical Burns: Week in Review

TORONTO–(BUSINESS WIRE)–PRESS RELEASE–FSD Pharma Inc. has announced the appointment of former U.S. Congressman Stephen Buyer to the company’s Board of Directors. The company also announced that it will complete a consolidation of its class A multiple voting shares and its class B subordinate voting shares, each on a 1 to 201 basis.

“In welcoming Steve Buyer to the FSD Pharma Board of Directors and announcing a share consolidation, the company has made an immense positive stride forward” said Raza Bokhari, MD, executive co-chairman and CEO. “Steve’s addition has further strengthened the independence and profile of the FSD Pharma Board of Directors; his broad leadership experience and pharmaceutical industry relationships will help enhance our visibility, especially among U.S. Institutional investors and on U.S. Capitol Hill. The share consolidation or reverse split of our stock is timed to advance our strategic plan to raise the profile of our company in the U.S. capital markets, which includes listing on a major U.S. stock exchange in the near future.”

“I’m pleased to be joining the FSD Pharma Board of Directors. The opportunity to participate in FSD’s growth at this stage is exciting. Unfortunately, auto immune diseases have clustered in my wife’s family. I am attracted by FSD’s medical research to tame and define the unknown by challenging the edges of medical science to provide relief to people suffering from fibromyalgia and other serious illnesses,” stated Buyer.

Stephen Buyer was a member of the United States House of Representatives, serving nine consecutive terms from January 1993 to January 2011. During Congressman Buyer’s long tenure in the Congress, he served on the Committees on Veterans Affairs, Armed Services, Judiciary, Energy and Commerce Committees and also served on the Military Compensation and Retirement Modernization Commission. He is presently the Managing Partner of the 10-Square Solution, LLC, focusing on business development, mergers and acquisitions, and representation before the federal government.

Congressman Buyer served as Chairman of the Committee on Veterans Affairs for the 109th Congress, as well as the Ranking Minority Member for the 110th and 111th Congresses. He centralized the VA’s IT architecture and was named to the Federal IT top 100. Congressman Buyer also served on the House Armed Services Committee from 1993 to 2001, including as Chair of the Subcommittee on Military Personnel in the 105th and 106th Congresses. He founded and co-chaired the National Guard and Reserve Components Caucus. He created the renewable energy portfolio for the Department of Defense and Veteran Affairs. He was the architect of TRICARE For Life and authored the U.S. military’s pharmacy redesign. His other Congressional assignments included service on the Health, Energy, and Technology subcommittees of the Committee on Energy and Commerce from 2001 to 2010, where he assisted in creating Medicare Part D, authored the electronic pedigree pharmaceuticals distribution system, served as a House Conferee on the Telecommunications Act of 1996, and lead the Congressional effort to reorganization of the U.S. Olympic Committee. He also served the House Committee on Judiciary from 1993 to 1999.

Congressman Buyer, as an Army Reserve officer, served four years on active duty, including a tour of duty in Iraq during the first Gulf War (1990-91) where he was awarded the Bronze Star as an Operational Law Judge Advocate. Prior to JAG, he was a Medical Service Corps Officer for four years. Congressman Buyer, after 30 years of service, retired with the rank of Colonel in the U.S. Army Reserve Judge Advocate General Corps.

Prior to his tenure in the United States Congress, Congressman Buyer served as a Special Assistant United States Attorney, Indiana Deputy Attorney General, and engaged in a private law practice.

Congressman Buyer is a distinguished military graduate of The Citadel in 1980 with a B.S. degree, and received his J.D. from Valparaiso University School of Law in 1984. He is a member of the Indiana and Virginia state Bars.

In addition, FSD is pleased to announce that its Board of Directors has approved the Consolidation on a 1:201 basis. Effective Oct. 16, 2019, with a record date of Oct. 17, 2019, the company expects to begin trading the Class B Shares on the Canadian Securities Exchange on a post-Consolidation basis under its existing name and ticker symbol. The new CUSIP and ISIN for the Class B Shares are 35954B206 and CA35954B2066, respectively.

The company currently has 1,582,966,252 Class B Shares outstanding and the consolidation will reduce the issued and outstanding Class B Shares to approximately 7,874,809 Class B Shares. The consolidation was approved by FSD shareholders at the company’s special meeting held on Jan. 22, 2019, and will allow the company to continue to pursue the listing of the Class B Shares on a major U.S. exchange.

The company will not be issuing fractional post-Consolidation FSD Shares in connection with the Consolidation. Where the consolidation would otherwise result in a shareholder being entitled to a fractional FSD Share, the number of post-consolidation FSD Shares issued to such holder of FSD Shares shall be rounded down to the nearest whole number of FSD Shares. In calculating such fractional interests, all FSD Shares held by a beneficial shareholder shall be aggregated.

A letter of transmittal with respect to the consolidation will be mailed to registered shareholders of the company. All registered shareholders with physical certificates will be required to send their certificates representing pre-Consolidation FSD Shares along with a completed letter of transmittal to the company’s transfer agent, Computershare Investor Services Inc., in accordance with the instructions provided in the letter of transmittal. Additional copies of the letter of transmittal can be obtained through Computershare. All shareholders who submit a duly completed letter of transmittal along with their pre-Consolidation FSD share certificate(s) to Computershare will receive a post-Consolidation share certificate. Shareholders who hold their FSD Shares through a broker or other intermediary and do not have FSD Shares registered in their name will not need to complete a letter of transmittal.

The exercise or conversion price and the number of FSD Shares issuable under any of the company’s outstanding warrants and stock options will be proportionately adjusted to reflect the consolidation in accordance with the respective terms thereof. After the consolidation, there will be approximately 1,033,782 stock options and warrants to purchase 576,499 Class B Shares outstanding.

The Class A Shares will also be consolidated on a 1:201 basis, such that post-consolidation there will be 72 Class A Shares issued and outstanding, each Class A Share representing 276,660 votes on all matters. Based on the current issued and outstanding number of FSD Shares, the Class A Shares collectively represent approximately 72 percent of the voting rights.

Published at Sat, 12 Oct 2019 14:00:00 +0000

Sacramento’s Cannabis Industry Ensnared in Expanding Campaign Finance Investigation

Sacramento’s Cannabis Industry Ensnared in Expanding Campaign Finance Investigation

Andrey Kukushkin, one of four businessmen indicted last week in a complex campaign finance investigation, is an officer at THC in Sacramento, according to reporting by Theresa Clift, Dale Kasler and Ryan Sabalow at the Sacramento Bee

Kukushkin is one of two named permit holders for THC, and he is the CFO of a company called Sharp Source, which, according to the Bee, owns THC. (As far as the business, THC stands for Twelve Hour Care.)

Garib Karapetyan is also named on the THC permit; he holds another seven cannabis retail dispensaries in Sacramento. The city allows a maximum of 30 cannabis retail storefronts.

The Bee points out that there is no overt connection between the funding for Karaptyan’s cannabis businesses and the broader campaign finance scheme detailed in a federal indictment—yet.

Broadly speaking, the investigation has targeted a cohort of foreign-born U.S. businessmen diverting international funds into U.S. political campaigns, including to Nevada politicians who may have been in a position to assist the four indicted men with cannabis business licensing in that state. The web of investigations is closely linked with the ongoing presidential impeachment inquiry in Washington, D.C., including the men’s ties to President Trump’s personal attorney, Rudy Giuliani.

Read the full Sacramento Bee story here.

Now that the campaign finance investigation has reeled in Kukushkin, the network of shared ownership interests in Sacramento’s cannabis market is under a microscope. Sacramento Mayor Darrell Steinberg has called for an investigation into Karapetyan’s consolidation of ownership in Sacramento’s cannabis market—and Kukushkin’s involvement.

“If this story is true, then our cannabis licensing process, which was designed to protect consumers and reward local law-abiding businesses, is being improperly exploited,” spokeswoman Mary Lynne Vellinga said in a public statement. “The mayor is calling for an immediate investigation and will lead an effort to add additional safeguards to the licensing process.”

Two sets of questions are raised here.

One is local: How did Karaptyan come to hold so many of the city’s cannabis dispensaries? And how is the city just now coming to realize the degree of ownership consolidation? What was Kukushkin’s involvement in the Sacramento businesses?

The other set of questions is an international concern: What is the extent of the campaign finance investigation’s inroads into the U.S. cannabis industry? Who else is involved?

Chris Kudialis at Leafly took a stab at the latter, detailing the misadventures of the four businessmen and their attempts at manipulating elections in Nevada to tilt the cannabis licensing process in their favor. Kukushkin, who already had a foothold in the California cannabis industry, played a visible role in this scheme.

andrey kukushkin cannabis industry ukraine campaign finance

According to the unsealed indictment in the Southern District of New York, Kukushkin was actively involved in funneling foreign cash into the 2018 gubernatorial race in Nevada, though he’d admitted to his fellow campaign finance violators that they were “two months too late to the game unless we change the rules,” referring to Nevada’s licensing deadlines last year. The businessmen sought to elect a Republican governor who could then nudge forward legislative amendments to Nevada’s cannabis law. Adam Laxalt, the Republican candidate in question, went on to lose the November 2018 election.

Read the full indictment below. The cannabis information begins at the bottom of page 10.

Along with the four businessmen, an unnamed “Foreign National 1” is listed in the indictment as the benefactor of this cannabis industry campaign finance scheme.

Mother Jones has connected a few dots and put forth an educated guess as to who Foreign National 1 might be—namely, a Russian businessman named Andrey Muraviev, who created a cannabis company in California with none other than Kukushkin and Karapetyan. The three men started a business called Legacy Botanical Company LLC, the license for which has since been suspended by the state of California. Muraviev’s role in the broader campaign finance investigation is as yet unconfirmed.

Nonetheless, after all of that, it’s clear that the campaign finance violations unfolding alongside the impeachment inquiry into Trump’s political dealings in Ukraine have at least some sort of connection to the cannabis industry. As this story develops, we’ll continue to track just how it all fits together.

U.S. v. Parnas et al by sandydocs on Scribd

Published at Mon, 14 Oct 2019 19:28:00 +0000

Next Green Wave Completes Third Premium Cannabis Harvest

Next Green Wave Completes Third Premium Cannabis Harvest

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”) is pleased to announce that it is processing its third cannabis harvest that will be sold for consumption as premium whole flower product, through its partner brands at selected dispensaries throughout California. The cannabis grown by NGW has consistently passed strict category three testing (CAT3) and meets all premium standards for the California market.

Cannot view this image? Visit: http://www.usmedicalmarijuana.net/wp-content/uploads/2019/10/LGpSmp.jpg

SDC cannabis products now available at Columbia Care

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6127/48696_nextgreenwave.jpg

Next Green Wave is continuing to build out its distribution strategy to deliver value to top tier dispensaries through its growing brands and products. Similar to a pharmaceutical distribution model, this will allow the company to bypass third party distributors, improve operational efficiency and deliver direct to the retailer. We are proud to announce that Columbia Care dispensaries have now been added to our growing network.

“In less than 6 months since opening our flagship facility, we have completed three harvests of premium quality, high THC cannabis, as well as fully scaled the entire space. As such, the facility is now in a perpetual harvest cycle in which roughly 14% of the flowering space is being processed every 10-14 days. At the same time, we are fortunate to have recently sourced and hired key additional talent to support and facilitate our expanding operations. We are now cultivating at full capacity and our employees will continue to play a significant role as we expand our market share by supplying the highest quality cannabis products to market in a timely fashion,” stated CEO Mike Jennings.

Cannot view this image? Visit: http://www.usmedicalmarijuana.net/wp-content/uploads/2019/10/oe7D9a.jpg

One of fourteen 1,300 sq ft growing rooms, two rooms will be harvested every 10-14 days

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6127/48696_f5e3f5d274b57885_003full.jpg

NGW is a fully integrated premium cannabis producer with 8 legacy brands and over 45 products marketed through its WEARESDC brand house. Based in Coalinga, California the company owns and operates a 35,000 sq ft state-of-the-art cultivation facility and is currently expanding extraction and other operations on its cannabis zoned campus. NGW has a seed library of over 120 cannabis strains which include multiple award-winning genetics and cultivars and is developing its nursery cloning operations with bio-tech leader Intrexon. To find out more visit us at www.nextgreenwave.com or follow us on TwitterInstagram, or LinkedIn.

On behalf of the board,

Michael Jennings, CEO
Next Green Wave Holdings Inc.

For more information regarding Next Green Wave, contact:
Caroline Klukowski
VP Corp. Development
Tel: +1 (778) 589-2848
IR@nextgreenwave.com

Next Green Wave Forward Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the risk factors included in the preliminary prospectus, including without limitation dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability, including closing of Tranche 1 and Tranche 2 of the Notes; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. Readers are encouraged to the review the section titled “Risk Factors” in NGW’s prospectus. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48696

copyright (c) newsfile corp. 2019

Source: Newsfile Corp. (October 11, 2019 – 8:34 AM EDT)

Published at Fri, 11 Oct 2019 12:46:34 +0000

Amyris Inc (NASDAQ:AMRS) Unveils The Financial Highlights For Its First Half 2019

Amyris Inc (NASDAQ:AMRS) Unveils The Financial Highlights For Its First Half 2019

Amyris Inc (NASDAQ:AMRS) has today
given highlights of how it has been performing over the first half of 2019. The
market will close on Wednesday, and shortly after, the business guru will hold
a conference call. It will take advantage of this conference call to undertake
a review of its business and financial results.

The turn of events in business

Apart
from this, the company says it has also filed its Form 10-K for the previous
year. The next step will be to file its Form 10-Qs for this year, and it will
be for both the first and second quarters. This should happen before the
conference call to be held on Wednesday. An official working with the company
says it is important for them to complete these delinquent SEC filings. This is
a way for them to comply with the Nasdaq listing rules.

Amyris
President, who is also the CEO, is happy with this year’s financial results.
According to him, the company has witnessed an impressive first-half. He thanks
the teams in the company for their dedication. These teams have delivered
greater volumes, and this has worked well towards attending to the fast-rising
demand. The company official says that it means quite much for them to exceed
their set business expectations.

He opined, “Our $300 million cannabinoid development collaboration is also exceeding our expectations. We are now on track to be the first company to produce multiple cannabinoids at commercial scale that are fermentation derived in 2020.”

A focus into the future

In
the upcoming conference call, the company intends to do several things. The
first one would be to discuss all aspects of its financial results. Secondly,
it will give updates on its business outlook this year. Thirdly, it will
discuss the way forward in terms of its ability to achieve even better results
in the future.

A
lot of the shareholders have been looking forward to seeing the company issue
out its customary release earings. A person well conversant with the matter,
but who wanted his identity kept anonymous says the company won’t be doing any
such thing.

Amyris
is set to unveil its financial results for both the first and the second
quarter of this year. It is going to do that through the Form 10-Qs filing.

Published at Thu, 10 Oct 2019 12:05:31 +0000

Vapen MJ President and CFO Bob Brilon to Present at Upcoming Investor Conferences

Vapen MJ President and CFO Bob Brilon to Present at Upcoming Investor Conferences

Vapen MJ (OTCQX:VAPNF; CSE:VAPN) (“Vapen MJ”) a fully integrated manufacturer and distributor of cannabis THC and hemp CBD products under the Vapen Brand, leveraging core expertise in extraction and marketing to build wholesale distribution through revenue and profit sharing partnerships, announced today that Bob Brilon, President and CFO will be presenting at the following conferences in October.

The Microcap Rodeo

  • Presentation date and time: Tuesday, October 15 at 3:50 pm CT with management hosting one-on-one meetings the same day
  • Location: Hilton Austin, Austin, TX
  • For more information visit the conference website: https://microcaprodeo.com

Benzinga Cannabis Capital Conference

  • Presentation date and time: Wednesday, October 23 at 2:20pm CT with management hosting one-on-one meetings the same day
  • Location: Palmer House, Chicago, IL
  • For more information visit the conference website and use code VAPENVIP for 20% off admission: https://benzingacannabisconference.com/chicago/

For more information on Vapen MJ, please visit our websites at www.VapenMJ.com or www.VapenCBD.com.

About Vapen MJ Ventures

Vapen MJ, through its wholly-owned subsidiaries, currently operates in the US as an agricultural technology, services and property management company utilizing a full vertical integration business model to oversee and execute all aspects of cultivation, extraction, manufacturing (THC and CBD cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of high margin Cannabis THC and Hemp CBD products under the Vapen Brand. Vapen MJ expansion includes partnering with cannabis license holders and hemp farms in multiple states within the US.

Forward Looking Statements
We Seek Safe Harbour.

Cision

View original content:http://www.prnewswire.com/news-releases/bob-brilon-vapen-mj-president-and-cfo-to-present-at-upcoming-investor-conferences-300936920.htmlSOURCE Vapen MJ Ventures Corporation

Copyright (c) 2019 PR Newswire Association,LLC. All Rights Reserved.

Published at Fri, 11 Oct 2019 13:05:23 +0000

Halo Labs Inc (OTCMKTS:AGEEF) Speaks Out On Its Oregon Business

Halo Labs Inc (OTCMKTS:AGEEF) Speaks Out On Its Oregon Business

Halo
Labs Inc (OTCMKTS:AGEEF)

says it won’t be business as usual for its Oregon business unit
(“ANM”). According to the company, the unit is set to generate orders
worth $1.8 million. If all moves according to plan, the unit might generate
sales totaling to $539,000.

Explaining
the rise in sales

The company says the rise in sales
orders may be partly to do with consumers stockpiling vape products. They may
have done that upon fears that Oregon would, at some point, place a ban on
these products.

However, the generated revenue will be
at a figure lower than $1.8 million. Analysts project that it might be
somewhere around $1.4 million.

Halo Labs has the figure for the
revenues of the first six months ended June 30, 2019. The report shows the
average unaudited monthly revenues standing at about $948,579.An official
working with the company but who wanted his identity kept anonymous said that
they have sufficient inventory. To him, there was no cause for alarm since that
inventory would see them fulfill the high level of orders.

Projections
into the future

This company is looking forward to
generating a great harvest from its Evans Creek grow site. A good harvest will
be a production of about 15,000 pounds (6,800 Kilos) of dry weight cannabis. It
seeks to obtain usable cannabis that will be beneficial to users.

A ban wouldn’t mean well for the
company since it will result in revenue losses. The company hopes the ban won’t
be imposed in Oregon. This would translate to a continued rise in sales.

Halo has also unveiled a direct
marketing campaign to the various licensed dispensaries within Oregon. In this
particular regard, it has outlined a wide range of benefits associated with the
DabTabsTM product line. These benefits by far surpass those associated with the
conventional vape cartridges.

Over the coming few weeks, Halo will
take on unveiling another similar campaign to all dispensaries in California.

Halo’s CEO has given his remarks
regarding the looming ban. He opines, “I encourage the state of Oregon to
focus its actions and messaging to curtail black market activities and not to
impose a ban on licensed manufacturers.”

Published at Fri, 11 Oct 2019 04:55:57 +0000